Danaher Corporation

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

DHRNYSE
HealthcareMedical - Diagnostics & Research
$202.52
$3.47(1.74%)
U.S. Market is Open · 15:35

Danaher Corporation (DHR)

Meyka AI Score

Z

Key Financials

Market Cap142.1B
P/E Ratio38.84
EPS (TTM)$7.98
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$192.46
3 Months$216.88
1 Year Target$210.10

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.41, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $210.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.84 and a market capitalization of 142.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.87%
5-Day Change
1.62%
1-Month Change
10.87%
3-Month Change
1.33%
6-Month Change
-16.30%
Year-to-Date (YTD) Change
-12.29%
1-Year Change
4.11%
3-Year Change
-4.73%
5-Year Change
-19.38%
All-Time (Max) Change
33604.32%

Contact Information

202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

610,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions